CN102481319A - 糖尿病前期和2型糖尿病中的载脂蛋白ciii - Google Patents

糖尿病前期和2型糖尿病中的载脂蛋白ciii Download PDF

Info

Publication number
CN102481319A
CN102481319A CN2010800370600A CN201080037060A CN102481319A CN 102481319 A CN102481319 A CN 102481319A CN 2010800370600 A CN2010800370600 A CN 2010800370600A CN 201080037060 A CN201080037060 A CN 201080037060A CN 102481319 A CN102481319 A CN 102481319A
Authority
CN
China
Prior art keywords
apociii
level
variant
type
prediabetes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2010800370600A
Other languages
English (en)
Chinese (zh)
Inventor
U·A·基尔南
D·内代利科维
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intrinsic Bioprobes Inc
Original Assignee
Intrinsic Bioprobes Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intrinsic Bioprobes Inc filed Critical Intrinsic Bioprobes Inc
Publication of CN102481319A publication Critical patent/CN102481319A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/775—Apolipopeptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
CN2010800370600A 2009-07-07 2010-07-03 糖尿病前期和2型糖尿病中的载脂蛋白ciii Pending CN102481319A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22350209P 2009-07-07 2009-07-07
US61/223,502 2009-07-07
PCT/US2010/040998 WO2011005718A1 (en) 2009-07-07 2010-07-03 Apolipoprotein ciii in pre- and type 2 diabetes

Publications (1)

Publication Number Publication Date
CN102481319A true CN102481319A (zh) 2012-05-30

Family

ID=43427312

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010800370600A Pending CN102481319A (zh) 2009-07-07 2010-07-03 糖尿病前期和2型糖尿病中的载脂蛋白ciii

Country Status (5)

Country Link
US (2) US20110008901A1 (https=)
EP (1) EP2451466B1 (https=)
JP (1) JP5876826B2 (https=)
CN (1) CN102481319A (https=)
WO (1) WO2011005718A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114354827A (zh) * 2022-03-21 2022-04-15 天津云检医疗器械有限公司 代谢标志物及其在制备2型糖尿病的风险预测试剂盒中的应用和试剂盒

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8557513B2 (en) * 2011-06-27 2013-10-15 Biocrine Ab Methods for treating and/or limiting development of diabetes
US9125255B2 (en) 2012-05-03 2015-09-01 Abl Ip Holding Llc Networked architecture for system of lighting devices having sensors, for intelligent applications
US9901562B2 (en) 2013-04-04 2018-02-27 Lycored Ltd. Anti-inflammatory omega-3 synergistic combinations
KR20200074975A (ko) 2017-10-31 2020-06-25 스태튼 바이오테크놀로지 비.브이. 항-ApoC3 항체 및 이의 사용 방법

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020161187A1 (en) * 2001-04-30 2002-10-31 George Jackowski Biopolymer marker indicative of disease state having a molecular weight of 1097 daltons
WO2006073195A1 (ja) * 2005-01-07 2006-07-13 Biomarker Science Co., Ltd 糖尿病の予知・診断方法および糖尿病予知・診断用キット
WO2007055341A1 (ja) * 2005-11-11 2007-05-18 Biomarker Science Co., Ltd. 示差的な糖尿病の予知・診断方法および糖尿病予知・診断用キット

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020164818A1 (en) * 1995-05-23 2002-11-07 Gruber Karl F. Mass spectrometric immunoassay analysis of specific proteins and variants present in various biological fluids
CA2434699A1 (en) * 2001-01-17 2002-10-17 Randall W. Nelson An integrated high throughput system for the analysis of biomolecules
JP2005503537A (ja) * 2001-01-17 2005-02-03 エー． タブス，ケモンズ 生体分子分析用ハイ・スループット統合システム
ES2398110T3 (es) * 2003-04-29 2013-03-13 Biocrine Ab ApoCIII y tratamiento y diagnóstico de la diabetes
US20070087448A1 (en) * 2004-02-16 2007-04-19 Nelsestuen Gary L Biological profiles and methods of use
US8343534B2 (en) * 2004-04-23 2013-01-01 The Procter & Gamble Company Tissue including a volatile rhinological composition
US20060110082A1 (en) * 2004-11-24 2006-05-25 Sauer-Danfoss Inc. Compact unitized cradle swashplate bearing
WO2006110082A1 (en) * 2005-04-11 2006-10-19 Astrazeneca Ab A method and a kit for diagnosing type 2 diabetes, metabolic syndrome, sub clinical atherosclerosis, myocardial infarct, stroke or clinical manifestations of diabetes.
WO2007025174A2 (en) * 2005-08-26 2007-03-01 Vascular And Endovascular Surgical Technologies, Inc. Endograft
US20070112055A1 (en) * 2005-09-30 2007-05-17 Glenmark Pharmaceuticals Limited Crystalline forms of almotriptan and processes for their preparation
AP2008004634A0 (en) * 2006-03-23 2008-10-31 Emelta De Guzman Breyer Apolipoprotein fingerprinting technique
WO2007132291A2 (en) * 2006-05-15 2007-11-22 Digilab, Inc. Biomarkers for pre-form of type 2 diabetes and methods for detecting the presence of absence of a pre-form of type 2 diabetes
US20080300170A1 (en) * 2006-09-01 2008-12-04 Cohava Gelber Compositions and methods for diagnosis and treatment for type 2 diabetes

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020161187A1 (en) * 2001-04-30 2002-10-31 George Jackowski Biopolymer marker indicative of disease state having a molecular weight of 1097 daltons
WO2006073195A1 (ja) * 2005-01-07 2006-07-13 Biomarker Science Co., Ltd 糖尿病の予知・診断方法および糖尿病予知・診断用キット
WO2007055341A1 (ja) * 2005-11-11 2007-05-18 Biomarker Science Co., Ltd. 示差的な糖尿病の予知・診断方法および糖尿病予知・診断用キット

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114354827A (zh) * 2022-03-21 2022-04-15 天津云检医疗器械有限公司 代谢标志物及其在制备2型糖尿病的风险预测试剂盒中的应用和试剂盒

Also Published As

Publication number Publication date
EP2451466A4 (en) 2012-12-12
US20150212100A1 (en) 2015-07-30
JP5876826B2 (ja) 2016-03-02
JP2012533066A (ja) 2012-12-20
WO2011005718A1 (en) 2011-01-13
EP2451466B1 (en) 2016-03-30
US20110008901A1 (en) 2011-01-13
EP2451466A1 (en) 2012-05-16

Similar Documents

Publication Publication Date Title
EP2984176B1 (en) Srm assay to indicate cancer therapy
US20080176333A1 (en) Analysis of Proteins from Biological Fluids Using Mass Spectrometric Immunoassay
JP2011515680A (ja) 糖尿病のためのバイオマーカーおよびアッセイ
US20070087448A1 (en) Biological profiles and methods of use
US20150212100A1 (en) Apolipoprotein ciii in pre- and type 2 diabetes
JP2013534315A (ja) ｃ−Ｓｒｃ選択反応モニタリングアッセイ
EP3035058B1 (en) Cancer marker screening method through detection of deglycosylation of glycoprotein and hepatocellular cancer marker
WO2007008158A1 (en) Method for diagnosing multiple sclerosis
KR101343286B1 (ko) 당뇨망막병증의 조기 진단용 마커 및 이의 용도
EP2451465B1 (en) Phenotypic ratio of serum amyloid in pre- and type 2 diabetes
CN112599239B (zh) 代谢物标志物及其在脑梗死诊断中的应用
Liang et al. Detection of salivary protein biomarkers of saliva secretion disorder in a primary Sjögren syndrome murine model
JP2010507093A (ja) バイオマーカー
WO2024109768A1 (zh) 基于血液代谢物的阿尔茨海默症标志物及其应用
CN112599237B (zh) 一种生物标志物及其在脑梗死诊断中的应用
KR102475926B1 (ko) 전신 홍반성 루푸스 진단용 바이오마커 조성물 및 이를 이용한 전신 홍반성 루푸스 진단에 필요한 정보를 제공하는 방법
CN112305089B (zh) 一种慢性肾病诊断生物标记物及其应用
KR101343285B1 (ko) 당뇨망막병증의 조기 진단용 마커 및 이의 용도
WO2005079410A2 (en) Biological profiles and methods of use
CN115469026B (zh) 用于检测环孢素a肾毒性相关标志物的检测试剂、试剂盒及其用途
CN115166100A (zh) 检测ffa和/或mag的试剂在制备预测ipah发病风险的产品中的应用
CN119804622A (zh) 一种用于2型遗传性血管水肿发作部位预测的n-糖链标志物、试剂盒及其应用
WO2023079706A1 (ja) 糖尿病性腎症の判定方法
CN120490487A (zh) Map1s作为诊断自身免疫性肝炎的生物标志物的应用
CN118091146A (zh) 基于血液代谢物的神经退行性疾病标志物及其应用

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20120530